Clinical Trial Update: TCD Followed by autoSCT for Newly Diagnosed MM Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial by the Korean Multiple Myeloma Working Party evaluating TCD followed by autologous stem cell transplantation in newly diagnosed multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Korean Multiple Myeloma Working Party | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN